Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Safety of Fluarix™/ Influsplit SSW® 2010/2011 or Pandemrix™

NCT01160237 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01160237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01160237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Safety of Fluarix™/ Influsplit SSW® 2010/2011 or Pandemrix™
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Terminated
Start date
August 31, 2010
Completion date
February 28, 2011
Enrollment
7 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

influenza